China's innovative drugs gain momentum in global expansion efforts2025-08-01
In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval.

Alcohol sales feast on holiday cheer2025-08-01
China's alcohol market has been cheered by its sales during the Spring Festival holiday, fueled by demand from a wide range of occasions such as gift exchanges and banquets among families and friends.

Boao Lecheng pilot zone explores fast track into China's medical market2025-08-01
Normally it would take three to five years for a foreign medical product or device to enter China's market, but in Lecheng, the country's only special medical zone on the southern tropical island of Hainan, the process takes just a few months.

Flu season sees spike in drug production2025-08-01
The surge in demand for respiratory disease medications in China has prompted significant output increases among major drugmakers, and industry experts foresee an increasing need for such remedies in the coming days.

Pharma firms eye Singapore for bigger global footprint2025-08-01
With improved innovative capabilities, competitiveness and international initiatives, Chinese pharmaceutical firms are expanding business in Singapore to tap into a new "battlefield".

Future industries ignite China's economic engine2025-08-01
A group of Chinese researchers have created a gene target therapy drug for amyotrophic lateral sclerosis, also known as ALS.

Shanghai eyes glory in gene therapy biz2025-08-01
Shanghai's municipal government said on Monday it aims to promote gene therapy in a big way.

Freshwater aquatic product sales set to surge2025-08-01
Given Chinese consumers' growing appetite for aquatic products, freshwater aquatic products will likely become more popular now due to concerns over the feared adverse impact on seafood of nuclear-contaminated wastewater discharged by Japan's Fukushima Daiichi power plant into the Pacific Ocean.

Pharma industry eyes healthy business2025-08-01
China's pull for foreign pharmaceutical companies will only increase despite uncertainties in China-US relations and the so-called de-risking strategy pursued by some Western countries, business executives and experts said.

Advanced tech aids pre-made food segment2025-08-01
Advanced equipment and technologies will not only help the booming pre-made food sector develop further, but will also offer a fresh and healthy alternative to customers, industry insiders said.

China's meat output tops record 90 mln tonnes in 20222025-08-01
China's total meat output hit a new record of over 90 million tonnes in 2022, accounting for about one-fourth of the global total, data from China Meat Association showed.

Qilu shipping cancer drug to US2025-08-01
Amid an ongoing cancer drug shortage, the United States Food and Drug Administration has been working with Chinese drugmaker Qilu Pharmaceutical Co Ltd to import the oncological medication cisplatin.

China's food industry sees steady growth in 20222025-08-01
China's food industry registered steady growth in 2022 and is expected to maintain growth momentum this year, according to an industrial association.

How Chinese pharma helps Mali build drug manufacturing capability2025-08-01
The pharmaceutical manufacturing industry in Mali had long been lagging behind, with the drug market predominantly monopolized by expensive imported drugs, leaving the Malian people in urgent need of medical care and resources. However, this situation has been reversed through a collaboration with a Chinese drugmaker.